Osmitrol Intravenous Infusion

Osmitrol Intravenous Infusion is a brand of medicine containing the active ingredient mannitol (diuretic medicines).

Find out more about active ingredients.

Consumer medicine information (CMI) leaflet

Developed by the pharmaceutical company responsible for this medicine in Australia, according to TGA regulations.

Osmitrol Intravenous (IV) Infusion

(Mannitol IV Infusion BP)


Consumer Medicine Information

What is in this leaflet?

This leaflet answers some common questions about the Osmitrol Intravenous Infusion (Mannitol IV Infusion BP). It does not contain all of the available information. All medicines have risks and benefits. Your doctor has weighed the risks of you using Osmitrol Intravenous Infusion (Mannitol IV Infusion BP) against the benefit they expect it will have for you.

It does not take the place of talking to your doctor or pharmacist. If you have any concerns about having this medicine, ask your doctor or pharmacist.

Back to top

What Osmitrol Intravenous Infusion (Mannitol IV Infusion BP) is used for?

The main ingredient in Osmitrol Intravenous Infusion (Mannitol IV Infusion BP) is Mannitol. Osmitrol Intravenous Infusion is used in the prevention and/or treatment of kidney failure before irreversible kidney failure becomes established, by promoting the urinary excretion of toxic substances.

Back to top

Before you are given the Osmitrol Intravenous Infusion (Mannitol IV Infusion BP)

Osmitrol Intravenous Infusion (Mannitol IV Infusion BP), should not be given to you if you have:

  • Sensitivity to mannitol
  • Severe kidney disease
  • Severe pulmonary disease
  • Active intracranial bleeding
  • Elevated intraocular pressure
  • Severe dehydration
  • Progressive kidney damage
  • Progressive heart failure
  • The expiry date printed on the pack is overdue

You must tell your doctor if you:

  • Have kidney disease
  • Have heart disease
  • Have any other illness
  • Are taking any prescription medicine or even non-prescription medicines
  • Are pregnant
  • Are breast feeing

Back to top

How Osmitrol Intravenous Infusion (Mannitol IV Infusion BP) is given?

How much it is given:

Your doctor will decide how much Osmitrol Intravenous Infusion (Mannitol IV Infusion BP), will be given to you, which depends on your need and condition. The medicine is a dripped Intravenous Infusion; therefore it should be given by using special equipment and attended by a health professional (doctor, trained nurse).

How it is given:

The Osmitrol Intravenous Infusion (Mannitol IV Infusion BP), will be given at a slow rate of Intravenous Infusion (drip) by your health professional. You will need to stay in a health institution (hospital, nursing home, etc), as it requires a special medical equipment to deliver the medicine into your circulation. This delivery must be attended by a health professional. The needle is normally placed in a large vein either on a central or peripheral blood vessel. Your doctor knows which of your large veins to use.

Case of overdose

The doctor or nurse infusing Osmitrol Intravenous Infusion (Mannitol IV Infusion BP), has had experience in the use of this sort of medicine, so it is unlikely that you will be given an overdose. However, in the case of an overdose, your health provider will take an appropriate action.

Back to top

While you are having Osmitrol Intravenous Infusion (Mannitol IV Infusion BP)

Discuss with your doctor the progress you have experience after the treatment, whether any complication has occurred, especially during the first few days of therapy. Frequent clinical evaluation and laboratory tests may be required. As Osmitrol Intravenous Infusion (Mannitol IV Infusion BP), is normally given in a hospital, your nurse provider will take records of the progress and unexpected reactions.

Back to top

Side effects

As with any medicine, some side effects may occur. Some patients may have undesirable side effects, such as, fever response. As with all other preparations similar to this product, inflammation of the veins on the site of the intravenous infusion may occur. Always tell your doctor if you have any unpleasant effects after receiving the Osmitrol Intravenous Infusion (Mannitol IV Infusion BP).

If any of the following happen, that is, nausea, vomiting, rhinitis (inflammation of the mucous membranes of the nose), local pain, skin necrosis, chills, dizziness, urticaria (redness of the skin or rash), hypotension (low blood pressure), hypertension (high blood pressure), heart racing, fever, chest pain, tell your health professional on duty immediately. They are symptoms of serious allergic reaction known as “anaphylactic shock” in medical terminology. Then, he/she will take an appropriate action promptly, such as to abort the Intravenous Infusion. Other serious reactions include kidney failure in those patients that are given large amounts of this product.

Back to top

Product descriptions

What Osmitrol Intravenous Infusion (Mannitol IV Infusion BP), looks like?

It is a clear colourless solution in a Viaflex plastic IV bag. It is a sterile solution and intended for intravenous slow Intravenous Infusion.

What is in Osmitrol Intravenous Infusion (Mannitol IV Infusion BP)?

The active component of Osmitrol Intravenous Infusion (Mannitol IV Infusion BP), is Mannitol. It is formulated in water for Intravenous Infusion.

Storage of Osmitrol Intravenous Infusion (Mannitol IV Infusion BP)

Exposure to heat should be minimised. Avoid excessive heat. It is recommended that the product be stored below 30°C.

Further information?

You can get more information from your doctor or pharmacist.

Name and address of the Sponsor

Baxter Healthcare Pty. Ltd
1 Baxter Drive,
Old Toongabbie NSW, 2146

This CMI was revised on 01 May 2006.

Date of the TGA Approval: as per PI approval, 21 March 2007

88-19-01-187

Back to top

CMI provided by MIMS Australia, January 2015  

Related information - Osmitrol Intravenous Infusion

Audience:
       

(Condition)
02 Nov 2012 Find reliable, independent information about brain swelling. You’ll find resources for consumers and health professionals about this health condition and any related treatments, medicines and medical tests.brain swelling is also known as cerebral oedema.
(Condition)
02 Nov 2012 Find reliable, independent information about kidney failure. You’ll find resources for consumers and health professionals about this health condition and any related treatments, medicines and medical tests.kidney failure is also known as renal failure.
(Medicine)
29 Oct 2012 Information on medicines available in Australia containing mannitol (diuretic medicines), including our latest evidence-based information and resources for health professionals and consumers. The active ingredient is the chemical in a medicine that makes it work. Medicines that contain the same active ingredient can be available under more than one brand name. Brands include both active ingredients and inactive ingredients. You'll find information about brands of medicines that contain mannitol (diuretic medicines) below, including their consumer medicine information (CMI) leaflets.